275 related articles for article (PubMed ID: 36676980)
1. Systematic Review: Contribution of the Gut Microbiome to the Volatile Metabolic Fingerprint of Colorectal Neoplasia.
van Vorstenbosch R; Cheng HR; Jonkers D; Penders J; Schoon E; Masclee A; van Schooten FJ; Smolinska A; Mujagic Z
Metabolites; 2022 Dec; 13(1):. PubMed ID: 36676980
[TBL] [Abstract][Full Text] [Related]
2. Urinary volatile organic compounds for colorectal cancer screening: A systematic review and meta-analysis.
van Liere ELSA; van Dijk LJ; Bosch S; Vermeulen L; Heymans MW; Burchell GL; de Meij TGJ; Ramsoekh D; de Boer NKH
Eur J Cancer; 2023 Jun; 186():69-82. PubMed ID: 37030079
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic Application of Volatile Organic Compounds as Potential Biomarkers for Detecting Digestive Neoplasia: A Systematic Review.
Dima AC; Balaban DV; Dima A
Diagnostics (Basel); 2021 Dec; 11(12):. PubMed ID: 34943554
[TBL] [Abstract][Full Text] [Related]
4. Fecal volatile organic compounds for early detection of colorectal cancer: where are we now?
Bosch S; Berkhout DJ; Ben Larbi I; de Meij TG; de Boer NK
J Cancer Res Clin Oncol; 2019 Jan; 145(1):223-234. PubMed ID: 30554400
[TBL] [Abstract][Full Text] [Related]
5. Urinary volatile organic compounds and faecal microbiome profiles in colorectal cancer.
McFarlane M; Millard A; Hall H; Savage R; Constantinidou C; Arasaradnam R; Nwokolo C
Colorectal Dis; 2019 Nov; 21(11):1259-1269. PubMed ID: 31282600
[TBL] [Abstract][Full Text] [Related]
6. Volatile organic compounds as new biomarkers for colorectal cancer: a review.
Di Lena M; Porcelli F; Altomare DF
Colorectal Dis; 2016 Jul; 18(7):654-63. PubMed ID: 26752703
[TBL] [Abstract][Full Text] [Related]
7. Altered gut metabolites and microbiota interactions are implicated in colorectal carcinogenesis and can be non-invasive diagnostic biomarkers.
Coker OO; Liu C; Wu WKK; Wong SH; Jia W; Sung JJY; Yu J
Microbiome; 2022 Feb; 10(1):35. PubMed ID: 35189961
[TBL] [Abstract][Full Text] [Related]
8. The roles of microbial products in the development of colorectal cancer: a review.
Fang Y; Yan C; Zhao Q; Xu J; Liu Z; Gao J; Zhu H; Dai Z; Wang D; Tang D
Bioengineered; 2021 Dec; 12(1):720-735. PubMed ID: 33618627
[TBL] [Abstract][Full Text] [Related]
9. The interplay of the gut microbiome, bile acids, and volatile organic compounds.
Sagar NM; Cree IA; Covington JA; Arasaradnam RP
Gastroenterol Res Pract; 2015; 2015():398585. PubMed ID: 25821460
[TBL] [Abstract][Full Text] [Related]
10. Systematic review: Gut microbiota in fecal samples and detection of colorectal neoplasms.
Amitay EL; Krilaviciute A; Brenner H
Gut Microbes; 2018 Jul; 9(4):293-307. PubMed ID: 29543545
[TBL] [Abstract][Full Text] [Related]
11. Gut microbiota-derived short-chain fatty acids and colorectal cancer: Ready for clinical translation?
Hou H; Chen D; Zhang K; Zhang W; Liu T; Wang S; Dai X; Wang B; Zhong W; Cao H
Cancer Lett; 2022 Feb; 526():225-235. PubMed ID: 34843863
[TBL] [Abstract][Full Text] [Related]
12. Volatile organic compounds in human matrices as lung cancer biomarkers: a systematic review.
Janssens E; van Meerbeeck JP; Lamote K
Crit Rev Oncol Hematol; 2020 Sep; 153():103037. PubMed ID: 32771940
[TBL] [Abstract][Full Text] [Related]
13. Breath based volatile organic compounds in the detection of breast, lung, and colorectal cancers: A systematic review.
Oakley-Girvan I; Davis SW
Cancer Biomark; 2017 Dec; 21(1):29-39. PubMed ID: 29060925
[TBL] [Abstract][Full Text] [Related]
14. Pectin supplement significantly enhanced the anti-PD-1 efficacy in tumor-bearing mice humanized with gut microbiota from patients with colorectal cancer.
Zhang SL; Mao YQ; Zhang ZY; Li ZM; Kong CY; Chen HL; Cai PR; Han B; Ye T; Wang LS
Theranostics; 2021; 11(9):4155-4170. PubMed ID: 33754054
[No Abstract] [Full Text] [Related]
15. Genome-resolved metaproteomic characterization of preterm infant gut microbiota development reveals species-specific metabolic shifts and variabilities during early life.
Xiong W; Brown CT; Morowitz MJ; Banfield JF; Hettich RL
Microbiome; 2017 Jul; 5(1):72. PubMed ID: 28693612
[TBL] [Abstract][Full Text] [Related]
16. The Role of Dietary Fibre in Modulating Gut Microbiota Dysbiosis in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.
Ojo O; Feng QQ; Ojo OO; Wang XH
Nutrients; 2020 Oct; 12(11):. PubMed ID: 33113929
[TBL] [Abstract][Full Text] [Related]
17. Urinary Volatile Organic Compound Analysis for the Diagnosis of Cancer: A Systematic Literature Review and Quality Assessment.
Wen Q; Boshier P; Myridakis A; Belluomo I; Hanna GB
Metabolites; 2020 Dec; 11(1):. PubMed ID: 33383923
[TBL] [Abstract][Full Text] [Related]
18. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
19. Fecal Volatile Organic Compounds and Microbiota Associated with the Progression of Cognitive Impairment in Alzheimer's Disease.
Ubeda C; Vázquez-Carretero MD; Luque-Tirado A; Ríos-Reina R; Rubio-Sánchez R; Franco-Macías E; García-Miranda P; Calonge ML; Peral MJ
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614151
[TBL] [Abstract][Full Text] [Related]
20. Analysis of urinary VOCs using mass spectrometric methods to diagnose cancer: A review.
da Costa BRB; De Martinis BS
Clin Mass Spectrom; 2020 Nov; 18():27-37. PubMed ID: 34820523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
